Discovery of BE2012, a First-in-Class REV-ERBα/β Antagonist with Favorable Selectivity and Pharmacokinetics, and In Vivo Efficacy in Inducing Key Myogenic Factors for Muscle Repair upon Acute Muscle Injury
用户6X7Ch8WUQ_gI
11天前
39
10
已完结
1. 系统已在2026-01-01 11:02:11对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c02749
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02749
其他信息:
出版社: American Chemical Society (ACS)
作者: Lingaiah Maram; Aurore-Cecile Valfort; Mohammad Homaidur Rahman; Hazem E. Okda; Mohamed Elagawany; Henry Politte; Kevin Appourchaux; Gonzalo Bedia-Diaz; Isabelle Côté; Lamees Hegazy; Thomas P. Burris; Bahaa Elgendy
